Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Farid El-Hajbi"'
Autor:
Ken Kato, Yuichiro Doki, Ian Chau, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih‐Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria Ignez Braghiroli, Eva Holtved, Tomoki Makino, Mariela Blum Murphy, Carlos Amaya‐Chanaga, Apurva Patel, Nan Hu, Yasuhiro Matsumura, Yuko Kitagawa, Jaffer Ajani
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Background First‐line nivolumab plus chemotherapy and nivolumab plus ipilimumab both demonstrated significant overall survival (OS) benefit versus chemotherapy in previously untreated patients with advanced esophageal squamous cell carcino
Externí odkaz:
https://doaj.org/article/59c4231e83f941f6a4719927e06f1ef1
Autor:
Stefano Kim, Jihane Boustani, Dewi Vernerey, Véronique Vendrely, Ludovic Evesque, Eric Francois, Laurent Quero, Francois Ghiringhelli, Christelle de la Fouchardière, Laëtitia Dahan, Oliver Bouché, Benoist Chibaudel, Farid El Hajbi, Chloé Vernet, Magali Rebucci-Peixoto, Alexandra Feuersinger, Christophe Maritaz, Christophe Borg
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundChemoradiotherapy alone is the standard treatment for locally advanced squamous cell anal carcinoma (SCAC). However, up to 50% of patients will experience recurrence; thus, there is a need for new treatments to improve outcomes. Modified do
Externí odkaz:
https://doaj.org/article/08ac6218fcf8493fbfa42d7f8be1d2e4
Autor:
Stefano Kim, Bruno Buecher, Thierry André, Marine Jary, François-Clément Bidard, François Ghiringhelli, Éric François, Julien Taieb, Denis Smith, Christelle de la Fouchardière, Jérôme Desramé, Emmanuelle Samalin, Aurélie Parzy, Nabil Baba-Hamed, Olivier Bouché, David Tougeron, Laëtitia Dahan, Farid El Hajbi, Marion Jacquin, Magali Rebucci-Peixoto, Laurie Spehner, Véronique Vendrely, Dewi Vernerey, Christophe Borg
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) regimen has become a new standard for the treatment of metastatic or unresectable locally advanced recurrent squamous cell carcinoma of the anus (SCCA) after demonstrating i
Externí odkaz:
https://doaj.org/article/07cff244a8334a279f68769e303b762a
Autor:
Antonin Vary, Loïc Lebellec, Frédéric Di Fiore, Nicolas Penel, Claire Cheymol, Emilia Rad, Farid El Hajbi, Astrid Lièvre, Julien Edeline, André Michel Bimbai, Marie-Cécile Le Deley, Anthony Turpin
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Most patients with advanced pancreatic adenocarcinoma (PA) treated with FOLFIRINOX experience adverse events requiring dose reduction. We aimed to assess the association between relative dose intensity (RDI) and disease control in a Europ
Externí odkaz:
https://doaj.org/article/c503d95fdec94c7eb3de50d752b7ba3e
Autor:
Stefano Kim, Aurélia Meurisse, Laurie Spehner, Morgane Stouvenot, Eric François, Bruno Buecher, Thierry André, Emmanuelle Samalin, Marine Jary, Thierry Nguyen, Farid El Hajbi, Nabil Baba-Hamed, Simon Pernot, Marie-Christine Kaminsky, Olivier Bouché, Jerome Desrame, Mustapha Zoubir, François Ghiringhelli, Aurélie Parzy, Christelle de la Fouchardiere, Fatiha Boulbair, Zaher Lakkis, Elodie Klajer, Marion Jacquin, Julien Taieb, Véronique Vendrely, Dewi Vernerey, Christophe Borg
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Aims: The addition of docetaxel to cisplatin and 5-fluorouracil (DCF) has shown promising efficacy in advanced squamous cell carcinoma of the anus (SCCA). Preliminary results of Epitopes-HPV01 study showed a high rate of long-lasting complete respons
Externí odkaz:
https://doaj.org/article/e9e6d7169fe0466ea10422572e935204
Autor:
Camille Evrard, Thomas Aparicio, Emilie Soularue, Karine Le Malicot, Jérôme Desramé, Damien Botsen, Farid El Hajbi, Daniel Gonzalez, Come Lepage, Olivier Bouché, David Tougeron, on behalf of the DURIGAST—PRODIGE 59 Investigators/Collaborators
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1211 (2022)
Efficacy of immune checkpoint inhibitors (ICI) as monotherapy in 2nd line treatment for gastric or gastro-oesophageal junction (GEJ) adenocarcinoma is low, with no evaluation of efficacy and safety of ICI combined with chemotherapy. The DURIGAST PROD
Externí odkaz:
https://doaj.org/article/e5f33636db76484d82559bf48a274df7
Autor:
Takashi Kojima, Sung-Bae Kim, Ken Kato, Antoine Hollebecque, Per Pfeiffer, Florian Lordick, Masahiro Tajika, Mark Ayers, Jared Lunceford, Manish Shah, Daniel Hochhauser, Peter Enzinger, Judith Raimbourg, Heung Tae Kim, A Craig Lockhart, Hendrick-Tobias Arkenau, Farid El-Hajbi, Pooja Bhagia, Z Alexander Cao, Shailaja Suryawanshi, Matt Marton
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/df03b38851d04671bfca314d3e6727c1
Autor:
Stefano Kim, Marine Jary, Thierry André, Véronique Vendrely, Bruno Buecher, Eric François, François-Clément Bidard, Sarah Dumont, Emmanuelle Samalin, Didier Peiffert, Simon Pernot, Nabil Baba-Hamed, Farid El Hajbi, Olivier Bouché, Jérôme Desrame, Aurélie Parzy, Mustapha Zoubir, Christophe Louvet, Jean-Baptiste Bachet, Thierry Nguyen, Meher Ben Abdelghani, Denis Smith, Christelle De La Fouchardière, Thomas Aparicio, Jaafar Bennouna, Jean-Marc Gornet, Marion Jacquin, Franck Bonnetain, Christophe Borg
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background The squamous cell carcinoma of the anus (SCCA) is a rare disease, but its incidence is markedly increasing. About 15% of patients are diagnosed at metastatic stage, and more than 20% with a localized disease treated by chemoradiot
Externí odkaz:
https://doaj.org/article/de947b484ce94cb3bfad51574aee5bb2
Autor:
Manish A Shah, Takashi Kojima, Daniel Hochhauser, Peter Enzinger, Judith Raimbourg, Antoine Hollebecque, Florian Lordick, Sung-Bae Kim, Masahiro Tajika, Albert Craig Lockhart, Hendrick-Tobias Arkenau, Farid El-Hajbi, Mukul Gupta, Per Pfeiffer, Pooja Bhagia, Zhu Alexander Cao, Jared Lunceford, Shailaja Suryawanshi, Mark Ayers, Matthew J Marton, Ken Kato
Publikováno v:
Future Oncology. 18:2783-2790
Aim: Investigate the relationship between response to pembrolizumab and expression of the 18-gene T cell-inflamed gene expression profile (TcellinfGEP) or PD-L1 combined positive score (CPS) in esophageal cancer. Materials & methods: This analysis in
Autor:
Aurelien Marabelle, Sylvie Chevret, Pierre Saintigny, Luis A. Diaz, Assia Lamrani-Ghaouti, Clotilde Simon, Frederic Legrand, Natalie Hoog-Labouret, Andrea Cercek, Neil H. Segal, Anthony Ferrari, Severine Tabone-Eglinger, Asha R. Krishnan, Guillem Argiles, Bill H. Diplas, Steven B. Maron, Michelle F. Lamendola-Essel, Dennis Stephens, Drew G. Gerber, Stephane Champiat, Jean-Charles Soria, Christophe Tournigand, Stephane Oudard, Farid El Hajbi, Diane Pannier, Thierry Andre, Olivier Bouche, Esma Saada-Bouzid, Sandrine Hiret, Frederic Rolland, Aude Flechon, Christelle de la Fouchardiere, Sophie Cousin, Muriel Duluc, Jean-Jacques Grob, Marielle Guillet, Amandine Bruyas, Rosine Guimbaud, Carlos Gomez-Roca, Damien Pouessel, Antoine Hollebecque, David Malka, Paule Augereau, Victor Simmet, Romain Cohen, Magali Svrcek, Julien Masliah-Planchon, Michael B. Foote, Valerie Attignon, Aurelien de Reynies, Lucas Michon, Nicolas Leulliot, Nadim Hamzaoui, Eric Pasmant, Ivan Bieche, Benoit Rousseau
Supplementary Figure from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68c6d0639646b5d1548ca8532028d21
https://doi.org/10.1158/2159-8290.22541047.v1
https://doi.org/10.1158/2159-8290.22541047.v1